novobiocin and Mastitis

A total of 9592 samples of half udder milk were collected monthly throughout lactation for bacteriological and somatic cell count (SCC) study from 1322 Churra ewe lactations from seven separate flocks enrolled in the recording scheme of the National Association of Spanish Churra Breeders in the Castile-Le6n region of Spain. Statistical analyses were carried out from a mixed model with random factor half udder or ewe for repeated measures. Test of significance of fixed effects of this mixed model showed significant effects of organisms, flock, parity, lactation stage, and birth type on SCC. Special reference must be made to novobiocin-sensitive coagulase-negative staphylococci, which represented more than 50% of the isolates and which elicited SCC geometric means of around 106/ml. In addition, the analysis of 4352 monthly test-day records for milk yield, SCC, and bacteriology showed that the ewes that were uninfected and infected by minor pathogens had the lowest SCC and the highest milk yields, whereas those infected by major pathogens had high SCC and milk yield losses between 8.8 and 10.1% according to the uni- or bilateral character of the infection. Finally, ewes infected by novobiocin-sensitive coagulase-negative staphylococci elicited SCC values similar to those of infections by major pathogens and milk yield losses ranging between those caused by minor and major pathogens. As a result, emphasis should be put on prevention of subclinical mastitis, particularly mastitis caused by novobiocin-sensitive coagulase-negative staphylococci in dairy sheep herds to improve microbiological and hygienic milk quality and to minimize losses in milk yield.

Topics: Animals; Anti-Bacterial Agents; Cell Count; Coagulase; Female; Lactation; Mastitis; Milk; Novobiocin; Random Allocation; Sheep; Sheep Diseases; Staphylococcal Infections; Staphylococcus

Staphylococcus aureus is a frequent cause of bovine mastitis worldwide. A model that may predict the efficacy of antimicrobial agents in the treatment of bovine mastitis induced by Staph. aureus was developed in lactating mice. Infection was established by the inoculation of lactating CF1 mice with Staph. aureus into the mammary gland via the teat duct. At the dose of bacteria used, 85-90% of the inoculated, untreated animals developed a nonlethal, acute mastitis within 48 h. Antibiotic treatment was administered subcutaneously or by the intramammary route. Lincosaminide antibiotics including lincomycin, clindamycin, and pirlimycin were evaluated in this system. Other compounds which have been used in therapy of bovine mastitis including novobiocin, penicillin G, ampicillin, cloxacillin and rifamycin-SV were used as reference antibiotics. Pirlimycin was the most effective of the antibiotics tested in this standardized system. Depending upon the route of administration, this novel lincosaminide was 15 to 95-fold more effective than clindamycin, three- to six-fold better than lincomycin, two- to ten-fold more effective than novobiocin, 13- to 17-times more effective than cloxacillin and 8- to 22-times better than rifamycin-SV on a weight-dose comparison. Penicillin G and ampicillin were the least effective drugs tested against mastitis induced by the beta-lactamase producing strain of Staph. aureus used in these assays. Pharmacokinetic experiments suggested that the greater effectiveness of pirlimycin compared to clindamycin and lincomycin was due to increased affinity for and prolonged retention in the mammary gland.

Topics: Animals; Anti-Bacterial Agents; Cattle; Clindamycin; Cloxacillin; Disease Models, Animal; Female; Injections; Injections, Subcutaneous; Kinetics; Lactation; Lincomycin; Lincosamides; Macrolides; Mammary Glands, Animal; Mastitis; Mastitis, Bovine; Mice; Microbial Sensitivity Tests; Novobiocin; Pregnancy; Rifamycins; Staphylococcal Infections

Topics: Communicable Diseases; Female; Humans; Mastitis; Novobiocin; Prednisolone